Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson Disease
Subhrangshu Guhathakurta, Min Kyung Song, Sambuddha Basu, Goun Je, Ana Clara Cristovao, Yoon-Seong Kim
Int Neurourol J. 2022;26(Suppl 2):S85-93. Published online 2022 Nov 30 DOI: https://doi.org/10.5213/inj.2222206.103
Citations to this article as recorded by 
Tetrahydrofolic acid accelerates amyloid fibrillization, decreases cytotoxic oligomers and suppresses their toxicity
Wenqian Wang, Xinming Wu, Qingfu Zhang, Tong Zhang, Luying Jiang, Lili Qu, Fuping Lu, Fufeng Liu
International Journal of Biological Macromolecules.2025; 290: 139041. CrossRef
Neuronal dysfunction and gene modulation by non-coding RNA in Parkinson’s disease and synucleinopathies
Rosaria Meccariello, Gian Carlo Bellenchi, Salvatore Pulcrano, Sebastian Luca D’Addario, Domenico Tafuri, Nicola B. Mercuri, Ezia Guatteo
Frontiers in Cellular Neuroscience.2024;[Epub] CrossRef
Tet1-mediated activation of the Ampk signaling by Trpv1 DNA hydroxymethylation exerts neuroprotective effects in a rat model of Parkinson’s disease
Yu Fan, Po Wang, Changchun Jiang, Jinyu Chen, Meili Zhao, Jiahui Liu
Functional & Integrative Genomics.2024;[Epub] CrossRef
Targeting epigenetic modifications in Parkinson's disease therapy
Dan Zhang, Jifa Zhang, Yuxi Wang, Guan Wang, Pan Tang, Yun Liu, Yiwen Zhang, Liang Ouyang
Medicinal Research Reviews.2023; 43(5): 1748. CrossRef
Role of Epigenetic Modifications in Parkinson’s Disease
Jian-Nan Zhang, Qian Li, Fei Yang
Epigenomics.2023; 15(10): 573. CrossRef
Epigenetic Dysfunction of Neurodegenerative Diseases, MeCP2 and More
Heh-In Im
International Neurourology Journal.2022; 26(Suppl 2): S83. CrossRef
Looking Forward to Saying Goodbye to COVID-19 and a Step Forward
Young Sam Cho
International Neurourology Journal.2022; 26(4): 259. CrossRef